Cannabis
from24/7 Wall St.
1 week agoCannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021
Federal cannabis policy is shifting, impacting ETFs focused on US cannabis operators due to rescheduling from Schedule I to Schedule III.
Amplify Seymour Cannabis ETF ( NYSEARCA:CNBS) posted a 17% gain in 2025, but that masks the real story. The fund surged 37% in December alone after President Trump signed an executive order directing Attorney General Pam Bondi to complete rulemaking for reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act. Reddit investors have been overwhelmingly bullish, with sentiment scores averaging 82 over the past quarter.